Search filters

List of works by Reed F Beall

A Method for Approximating Future Entry of Generic Drugs

scientific article published on 11 June 2018

A method for understanding generic procurement of HIV medicines by developing countries with patent protection

scientific article published on 04 May 2017

A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications

scientific article published on 18 September 2019

Approximating Future Generic Entry for New Drugs

scientific article published on 01 March 2019

Commentary: Expedited Regulatory Review of Low-Value Drugs

scientific article published on 01 May 2020

Comparing Onset of Biosimilar Versus Generic Competition in the United States

scientific article published on 04 July 2020

Comparing alternative design options for chronic disease prevention interventions.

scientific article

Compulsory Licenses: The Authors Reply

scientific article published on 01 June 2015

Compulsory licensing often did not produce lower prices for antiretrovirals compared to international procurement

scientific article published on March 2015

Could patents interfere with the development of a cardiovascular polypill?

scientific article published on 18 August 2016

Effectiveness of individual-focused interventions to prevent chronic disease

scientific article published on September 2014

Estimating The Cost Of Delayed Generic Drug Entry To Medicaid

scientific article published on 01 June 2020

Evaluating The Impact Of The Orphan Drug Act's Seven-Year Market Exclusivity Period

scientific article published on 01 May 2018

Generic Competition for Drugs Treating Rare Diseases

scientific article published on 01 December 2020

Global clinical trial mobilization for COVID-19: higher, faster, stronger

scientific article published on 07 August 2020

How will recent trade agreements that extend market protections for brand-name prescription pharmaceuticals impact expenditures and generic access in Canada?

scientific article published on 20 September 2019

In which developing countries are patents on essential medicines being filed?

scientific article

Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?

scientific article

Lowering the High Cost of Cancer Drugs--III.

scientific article published in March 2016

Major Events in the Life Course of New Drugs, 2000-2016

scientific article published on 01 March 2019

Modes of delivery in preventive intervention studies: a rapid review

scientific article published on July 2014

New Drug Formulations and Their Respective Generic Entry Dates

scientific article published on 01 February 2019

Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines

scientific article

Patent term restoration for top-selling drugs in the United States

scientific article published on 25 July 2018

Pre-market development times for biologic versus small-molecule drugs

scientific article published on 01 July 2019

Tertiary patenting on drug-device combination products in the United States

scientific article published in February 2018

The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

scientific article published on 01 February 2019

The global intellectual property ecosystem for insulin and its public health implications: an observational study.

scientific article

The impact of pharmaceutical rebates on patients' drug expenditures

scientific article published on 01 March 2019

The time for pharmaceutical compulsory licensing has expired

scientific article published on 01 August 2012

Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis

scientific article

Upstream solutions for price-gouging on critical generic medicines

scientific article published on 2 May 2016

Which patent and where? Why international patent transparency by companies is needed for medicines

scientific article published in September 2016

Will inter partes review speed US generic drug entry?

scientific article published in December 2017

Paulina is supported by:

About Paulina

Help